BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25704361)

  • 1. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.
    Yang QJ; Jerath A; Bies RR; Wąsowicz M; Pang KS
    Biopharm Drug Dispos; 2015 Jul; 36(5):294-307. PubMed ID: 25704361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen.
    Jerath A; Yang QJ; Pang KS; Looby N; Reyes-Garces N; Vasiljevic T; Bojko B; Pawliszyn J; Wijeysundera D; Beattie WS; Yau TM; Wąsowicz M
    Anesth Analg; 2018 Dec; 127(6):1323-1332. PubMed ID: 29309319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.
    Dowd NP; Karski JM; Cheng DC; Carroll JA; Lin Y; James RL; Butterworth J
    Anesthesiology; 2002 Aug; 97(2):390-9. PubMed ID: 12151929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery.
    Grassin-Delyle S; Couturier R; Abe E; Alvarez JC; Devillier P; Urien S
    Anesthesiology; 2013 Apr; 118(4):853-62. PubMed ID: 23343649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.
    Gertler R; Gruber M; Grassin-Delyle S; Urien S; Martin K; Tassani-Prell P; Braun S; Burg S; Wiesner G
    Br J Clin Pharmacol; 2017 Aug; 83(8):1745-1757. PubMed ID: 28245519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass.
    Wesley MC; Pereira LM; Scharp LA; Emani SM; McGowan FX; DiNardo JA
    Anesthesiology; 2015 Apr; 122(4):746-58. PubMed ID: 25585004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Goobie SM; Meier PM; Sethna NF; Soriano SG; Zurakowski D; Samant S; Pereira LM
    Clin Pharmacokinet; 2013 Apr; 52(4):267-76. PubMed ID: 23371895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass.
    Sharma V; Fan J; Jerath A; Pang KS; Bojko B; Pawliszyn J; Karski JM; Yau T; McCluskey S; Wąsowicz M
    Anaesthesia; 2012 Nov; 67(11):1242-50. PubMed ID: 22827564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass.
    Tae YM; Kwak JG; Kim BH; Jang IJ; Kim WH
    J Clin Pharmacol; 2011 Aug; 51(8):1163-76. PubMed ID: 20926755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and convulsive seizures after isolated coronary artery bypass surgery: the role of cardiopulmonary bypass and renal function.
    Hulde N; Zittermann A; Deutsch MA; von Dossow V; Gummert JF; Koster A
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):538-540. PubMed ID: 31958119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pharmacokinetic and Plasmin-Generation Pharmacodynamic Assessment of a Tranexamic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass.
    Strauss ER; Li S; Henderson R; Carpenter R; Guo D; Thangaraju K; Katneni U; Buehler PW; Gobburu JVS; Tanaka KA
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2473-2482. PubMed ID: 35094925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tranexamic acid concentrations during cardiopulmonary bypass.
    Fiechtner BK; Nuttall GA; Johnson ME; Dong Y; Sujirattanawimol N; Oliver WC; Sarpal RS; Oyen LJ; Ereth MH
    Anesth Analg; 2001 May; 92(5):1131-6. PubMed ID: 11323334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients.
    Abou-Diwan C; Sniecinski RM; Szlam F; Ritchie JC; Rhea JM; Tanaka KA; Molinaro RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):553-6. PubMed ID: 21300577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic monitoring of tranexamic acid concentration: high-throughput analysis with solid-phase microextraction.
    Bojko B; Vuckovic D; Mirnaghi F; Cudjoe E; Wasowicz M; Jerath A; Pawliszyn J
    Ther Drug Monit; 2012 Feb; 34(1):31-7. PubMed ID: 22249343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a novel technique, solid phase microextraction, to measure tranexamic acid in patients undergoing cardiac surgery.
    Wąsowicz M; Jerath A; Bojko B; Sharma V; Pawliszyn J; McCluskey S
    Can J Anaesth; 2012 Jan; 59(1):14-20. PubMed ID: 22045433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
    Grassin-Delyle S; Tremey B; Abe E; Fischler M; Alvarez JC; Devillier P; Urien S
    Br J Anaesth; 2013 Dec; 111(6):916-24. PubMed ID: 23880099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial.
    Grassin-Delyle S; Shakur-Still H; Picetti R; Frimley L; Jarman H; Davenport R; McGuinness W; Moss P; Pott J; Tai N; Lamy E; Urien S; Prowse D; Thayne A; Gilliam C; Pynn H; Roberts I
    Br J Anaesth; 2021 Jan; 126(1):201-209. PubMed ID: 33010927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
    Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
    Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.